Russ Montgomery, PhD is the Senior Director of U.S. Value Assessment Strategy at GSK. In his role, he is responsible for value evidence planning and response to assessments conducted by government agencies and HTA organizations and external engagement on value-related policies and methods best practices.
Prior to joining GSK, Russ worked on global value policy and U.S. value assessment planning at Gilead Science. Additionally, he previously worked as a Vice President at Discern Health (now part of Real Chemistry), leading consulting work on quality and value issues, and held policy roles at the Centers for Medicare and Medicaid Services and health agencies in Maryland and Arkansas. Early in his career, he led projects on value assessment methods at the Center for Medical Technology Policy. He holds a PhD in health services research from Johns Hopkins University, where he previously served as affiliate faculty.
